References
- Ajami A, Rafiei A, Naghshvar F, et al (2009). Association of human leukocyte antigen and esophageal cancer in North of Iran. Pak J Biol Sci, 12, 1585-8. https://doi.org/10.3923/pjbs.2009.1585.1588
- Akhavan A, Binesh F, Heidari S (2014). Survival of brain metastatic patients in Yazd, Iran. Asian Pac J Cancer Prev, 15, 3571-4. https://doi.org/10.7314/APJCP.2014.15.8.3571
- Brufsky AM, Mayer M, Rugo HS, et al (2011). Central nervous system metastases in patients with HER2-positive metastatic breast cancer: incidence, treatment, and survival in patients from registHER. Clin Cancer Res, 17, 4834-43. https://doi.org/10.1158/1078-0432.CCR-10-2962
- Demircioglu F, Demirci U, Akmansu M (2013). Lymph node ratio assessment of brain metastasis in early breast cancer cases. Asian Pac J Cancer Prev, 14, 1665-7. https://doi.org/10.7314/APJCP.2013.14.3.1665
- Duchnowska R, Szczylik C (2005). Central nervous system metastases in breast cancer patients administered trastuzumab. Cancer Treat Rev, 31, 312-8. https://doi.org/10.1016/j.ctrv.2005.04.008
- Gabos Z, Sinha R, Hanson J, et al (2006). Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer. J Clin Oncol, 24, 5658-63. https://doi.org/10.1200/JCO.2006.07.0250
- Holloway PJ, Worthington HV (2002). What is CONSORT? How to publish a research project. Health Education J, 61, 293-8. https://doi.org/10.1177/001789690206100402
- Lin NU, Winer EP (2007). Brain metastases: the HER2 paradigm. Clin Cancer Res, 13, 1648-55. https://doi.org/10.1158/1078-0432.CCR-06-2478
- Lu D, Zhang H, Koo H, et al (2005). A fully human recombinant IgG-like bispecific antibody to both the epidermal growth factor receptor and the insulin-like growth factor receptor for enhanced antitumor activity. J Biol Chem, 280, 19665-72. https://doi.org/10.1074/jbc.M500815200
- Pazhoomand R, Keyhani E, Banan M, et al (2013). Detection of HER2 status in breast cancer: comparison of current methods with MLPA and real-time RT-PCR. Asian Pac J Cancer Prev, 14, 7621-8. https://doi.org/10.7314/APJCP.2013.14.12.7621
- Saip P, Cicin I, Eralp Y, et al (2008). Factors affecting the prognosis of breast cancer patients with brain metastases. Breast, 17, 451-8. https://doi.org/10.1016/j.breast.2008.03.004
- Slamon DJ, Clark GM, Wong SG, et al (1987). Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science, 235, 177-82. https://doi.org/10.1126/science.3798106
- Taghavi A, Fazeli Z, Vahedi M, et al (2012). Increased trend of breast cancer mortality in Iran. Asian Pac J Cancer Prev, 13, 367-70. https://doi.org/10.7314/APJCP.2012.13.1.367
- Tomasello G, Bedard PL, de Azambuja E, et al (2010). Brain metastases in HER2-positive breast cancer: the evolving role of lapatinib. Crit Rev Oncol Hematol, 75, 110-21. https://doi.org/10.1016/j.critrevonc.2009.11.003
- von Elm E, Altman DG, Egger M, et al (2007). The Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Bull WHO, 85, 867-72.
- Yarden Y (2001). The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities. Eur J Cancer, 37, 3-8.
- Yau T, Swanton C, Chua S, et al (2006). Incidence, pattern and timing of brain metastases among patients with advanced breast cancer treated with trastuzumab. Acta Oncol, 45, 196-201. https://doi.org/10.1080/02841860500486630
Cited by
- Biopsy of enlarging lesions after stereotactic radiosurgery for brain metastases frequently reveals radiation necrosis vol.19, pp.10, 2017, https://doi.org/10.1093/neuonc/nox090